BiotechTube
Home/Aclaris Therapeutics/Robert A. Doody, Jr., J.D.
RA

Robert A. Doody, Jr., J.D.

Chief Business Officer

Aclaris Therapeutics

Therapeutic Areas

ImmunologyDermatologyRheumatologyGastroenterology

Aclaris Therapeutics Pipeline

DrugIndicationPhase
ATI-450 (zunsemetinib)Rheumatoid ArthritisPhase 2b
ATI-1777Atopic DermatitisPhase 2b
ATI-2138Alopecia AreataPhase 2a
Bosakitug (ATI-045)Atopic DermatitisPhase 2

Leadership Team at Aclaris Therapeutics

DJ
Douglas J. Manion, M.D.
President and Chief Executive Officer
DN
Dr. Neal Walker, D.O., M.B.A.
Co-founder and Chair of the Board of Directors
DS
Dr. Stuart D. Shanler, M.D.
Chief Scientific Officer
View full Aclaris Therapeutics profile